206 related articles for article (PubMed ID: 35283481)
1. Hypoxia-induced long noncoding RNA NR2F1-AS1 maintains pancreatic cancer proliferation, migration, and invasion by activating the NR2F1/AKT/mTOR axis.
Liu Y; Chen S; Cai K; Zheng D; Zhu C; Li L; Wang F; He Z; Yu C; Sun C
Cell Death Dis; 2022 Mar; 13(3):232. PubMed ID: 35283481
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA NR2F1-AS1 plays a carcinogenic role in gastric cancer by recruiting transcriptional factor SPI1 to upregulate ST8SIA1 expression.
Zuo F; Zhang Y; Li J; Yang S; Chen X
Bioengineered; 2021 Dec; 12(2):12345-12356. PubMed ID: 34738863
[TBL] [Abstract][Full Text] [Related]
3. LncRNA NR2F1-AS1 is involved in the progression of endometrial cancer by sponging miR-363 to target SOX4.
Wang L; Zhao S; Mingxin YU
Pharmazie; 2019 May; 74(5):295-300. PubMed ID: 31109400
[TBL] [Abstract][Full Text] [Related]
4. The EMT-induced lncRNA NR2F1-AS1 positively modulates NR2F1 expression and drives gastric cancer via miR-29a-3p/VAMP7 axis.
Li D; Xu M; Wang Z; Huang P; Huang C; Chen Z; Tang G; Zhu X; Cai M; Qin S
Cell Death Dis; 2022 Jan; 13(1):84. PubMed ID: 35082283
[TBL] [Abstract][Full Text] [Related]
5. STAT3 activates the transcription of lncRNA NR2F1-AS1 to promote the progression of melanoma via regulating the miR-493-5p/GOLM1 axis.
Bai M; Wu ZZ; Huang YL; Ke J; Xu Q; Wang X
J Gene Med; 2021 Jul; 23(7):e3338. PubMed ID: 33822440
[TBL] [Abstract][Full Text] [Related]
6. Lnc NR2F1-AS1 Promotes Breast Cancer Metastasis by Targeting the MiR-25-3p/ZEB2 Axis.
Zhai D; Zhou Y; Kuang X; Shao F; Zhen T; Lin Y; Wang Q; Shao N
Int J Med Sci; 2023; 20(9):1152-1162. PubMed ID: 37575267
[No Abstract] [Full Text] [Related]
7. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
[TBL] [Abstract][Full Text] [Related]
8. HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway.
Chen T; Liu R; Niu Y; Mo H; Wang H; Lu Y; Wang L; Sun L; Wang Y; Tu K; Liu Q
Cell Death Dis; 2021 Dec; 12(12):1152. PubMed ID: 34903711
[TBL] [Abstract][Full Text] [Related]
9. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
[TBL] [Abstract][Full Text] [Related]
10. LncRNA NR2F1-AS1 was involved in azacitidine resistance of THP-1 cells by targeting IGF1 with miR-483-3p.
Hu C; Li S; Fu X; Zhao X; Peng J
Cytokine; 2023 Feb; 162():156105. PubMed ID: 36527891
[TBL] [Abstract][Full Text] [Related]
11. NR2F1-AS1 regulated miR-423-5p/SOX12 to promote proliferation and invasion of papillary thyroid carcinoma.
Yang C; Liu Z; Chang X; Xu W; Gong J; Chai F; Cui D
J Cell Biochem; 2020 Feb; 121(2):2009-2018. PubMed ID: 31692033
[TBL] [Abstract][Full Text] [Related]
12. IFN-γ affects pancreatic cancer properties by MACC1-AS1/MACC1 axis via AKT/mTOR signaling pathway.
Shi XY; Zhang XL; Shi QY; Qiu X; Wu XB; Zheng BL; Jiang HX; Qin SY
Clin Transl Oncol; 2022 Jun; 24(6):1073-1085. PubMed ID: 35037236
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA NR2F1-AS1 promotes the malignancy of non-small cell lung cancer via sponging microRNA-493-5p and thereby increasing ITGB1 expression.
Zhang C; Wu S; Song R; Liu C
Aging (Albany NY); 2020 Aug; 13(5):7660-7675. PubMed ID: 32784268
[TBL] [Abstract][Full Text] [Related]
15. NR2F1-induced NR2F1-AS1 promotes esophageal squamous cell carcinoma progression via activating Hedgehog signaling pathway.
Zhang Y; Zheng A; Xu R; Zhou F; Hao A; Yang H; Yang P
Biochem Biophys Res Commun; 2019 Nov; 519(3):497-504. PubMed ID: 31530388
[TBL] [Abstract][Full Text] [Related]
16. NR2F1-AS1 Acts as an Oncogene in Breast Cancer by Competitively Binding with miR-641.
Zhong Y; Zeng W
J Healthc Eng; 2022; 2022():6778199. PubMed ID: 35083026
[TBL] [Abstract][Full Text] [Related]
17. The emerging role of NR2F1-AS1 in the tumorigenesis and progression of human cancer.
Luo D; Liu Y; Yuan S; Bi X; Yang Y; Zhu H; Li Z; Ji L; Yu X
Pathol Res Pract; 2022 Jul; 235():153938. PubMed ID: 35552086
[TBL] [Abstract][Full Text] [Related]
18. NR2F1-AS1: A Functional Long Noncoding RNA in Tumorigenesis.
Hu J; Peng F; Qiu X; Yang J; Li J; Shen C; Yuan C
Curr Med Chem; 2023; 30(37):4266-4276. PubMed ID: 36644870
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p/CCND1 axis.
Guo F; Fu Q; Wang Y; Sui G
J Cell Mol Med; 2019 Sep; 23(9):5907-5919. PubMed ID: 31304680
[TBL] [Abstract][Full Text] [Related]
20. LncRNA NR2F1-AS1 promotes proliferation and metastasis of ESCC cells via regulating EMT.
Ren P; Zhang H; Chang L; Hong XD; Xing L
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3686-3693. PubMed ID: 32329844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
